Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...

Based in Cambridge, Massachusetts, Moderna, Inc. (MRNA) is a leading biotechnology company that develops messenger RNA (mRNA) ...

We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this article, we are going to take a ...

On Monday, Moderna Inc (MRNA) stock saw a decline, ending the day at $53.8 which represents a decrease of $-0.30 or -0.55% from the prior close of $54.1. The stock opened at $53.82 and touched a low ...

TD Cowen analyst Tyler Van Buren has maintained their neutral stance on MRNA stock, giving a Hold rating on October 17. Tyler Van ...

In this article, we are going to take a look at where Moderna Inc. (NASDAQ:MRNA) stands against the other QQQ stocks. Navigating High Valuations and Stock Opportunities Several recent discussions ...

At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II dose-ranging trial for mRNA-1403, a vaccine ...

Moderna Inc.’s shots for Covid-19 and respiratory syncytial virus infringe as many as seven GSK Plc patents related to mRNA ...

Moderna Inc. closed $112.18 short of its 52-week high ($170.47), which the company achieved on May 24th.

Shares of Moderna Inc. MRNA slid 4.59% to $54.82 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.04% to ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other Worst Performing NASDAQ Stock in 2024. Markets have been soaring for the better part of ...